A PHASE 1B, FIRST IN HUMAN, DOSE ESCALATION AND EXPANSION, MULTICENTER STUDY OF XMT- 1660 IN PARTICIPANTS WITH SOLID TUMORS Monika Chaudhry | June 4, 2022
